Serpentine Supravenous Hyperpigmentation Experience and Body Image in Patients with Cancer Receiving Chemotherapy

Main Article Content

Apatnipa Boonlee
Bualuang Sumdaengrit
Tiraporn Junda

Abstract

This descriptive research aimed to explore the symptom experience of serpentine supravenous hyperpigmentation, the perception of severity, distress level, and body image in patients with cancer receiving chemotherapy. The Symptom Management Theory was used as a conceptual framework. Eighty participants receiving chemotherapy were recruited from one chemotherapy ward at a university hospital in Bangkok. Four instruments were used to collect data. The questionnaires consisted of 1) the Personal Questionnaire, 2) the Perception and Severity of Serpentine Supravenous Hyperpigmentation Questionnaire, 3) the Distress Scale,and 4) the Body Image Scale. Data were analyzed using descriptive statistics. The results revealed that the average age of the sample was 59.43 years. Most participants were patients with solid tumor cancer, with which most of them were colon cancer (62.50%), stage 4 (63.75%), and treated with 5-fluorouracil as the component (90%). Approximately half of the appearance of hyperpigmentation (53.75%) began with black patches, with a soft appearance along the vein undergoing chemotherapy; the skin and dark veins were found most in the inner arm area (51.25%). The serpentine supravenous hyperpigmentation had moderate severity but produced low-lowest distress in the sample. The top three distresses included: 1)concern with high pigments along the vein receiving chemotherapy, 2) concern with selecting clothes to wear, and 3) feelings of embarrassment and lack of confidence, respectively.Perceived body image of the sample was rated as high. The results of this study could be used as basic knowledge for nurses and health care providers to develop a symptom management program for reducing the effects of the hyperpigmentation in patients with cancer.
Keywords: Chemotherapy, Serpentine supravenous hyperpigmentation, Distress, Body image

Article Details

How to Cite
1.
Boonlee A, Sumdaengrit B, Junda T. Serpentine Supravenous Hyperpigmentation Experience and Body Image in Patients with Cancer Receiving Chemotherapy. Nurs Res Inno J [Internet]. 2022 Dec. 22 [cited 2024 Apr. 29];28(3). Available from: https://he02.tci-thaijo.org/index.php/RNJ/article/view/252954
Section
บทความวิจัย

References

International Agency for Research on Cancer. Estimated number of new case in 2020, worldwide, both sexes, all age; 2020 [cited 2020 July 22]. Available from World Health Organization Web site: https://gco.iarc.fr/today/online-analysis-pie v=2020&mode=cancer&mode_population=continents&population=900

&populations=900&key=total&sex=0&cancer=39&type=0&statistic=5&prevalence

=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items

=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0

Faculty of Medicine Siriraj Hospital. Faculty of Medicine 4 institutes join forces to present “Correct anti-cancer policy to reduce incidences, reduce disability and death from cancer in Thailand” to consider the agenda of the National Health Assembly; 2019 [cited 2020 July 22].Available from Faculty of Medicine Siriraj Hospital Website: https://www.si.mahidol.ac.th/th/hotnewsdetail.asp?hn_id=2422

Meecharoen W, Kalated T, Nutra K. Quality of life of cancer patients receiving chemotherapy and their family caregivers. Journal of Nursing and Health Care. 2018;36(4):52-61. (in Thai)

Hazelwood DM, Koeck S, Wallner M, Anderson KH,Mayer H. Patients with cancer and family caregivers:management of symptoms caused by cancer or cancer therapy at home. Heilberufe Science. 2012;3(4):149-58. doi: 10.1007/s16024-012-0118-z.

Noori M, Hunter-Ellul L, Kelly B. Serpentine supravenous hyperpigmentation following cisplatin and pemetrexed chemotherapy. Cutis. 2017;99(4):E20-22.

Das A, Kumar D, Mohanty S, Mondal AK, Chowdhury SN, Bandyopadhyay D. Serpentine supravenous hyperpigmentation induced by docetaxel. Indian J Dermatol Venereol Leprol. 2015;81(4):434-6. doi:10.4103/0378-6323.156191.

Lancman G, Steinberg A, Gabrilove J. Serpentine supravenous hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL. Int J Hematol Oncol Stem Cell Res. 2018;12(1):1-3.

Lau JF, Dean SM, Rooke TW, Olin JW. Serpentine supravenous hyperpigmentation due to hydroxychl oroquine. Vasc Med. 2016;21(6):558-9. doi:10.1177/1358863X16650276.

Suvirya S, Agrawal A, Parihar A. 5-Fluorouracil-induced bilateral persistent serpentine supravenous hyperpigmented eruption, bilateral mottling of palms and diffuse hyperpigmentation of soles. BMJ Case Rep. 2014 Oct21;2014: bcr2014206793. doi: 10.1136/bcr-2014-206793.

Swathi T, Sucharitha R, Subash. VK, Rao AY, Prakash CSK. Three case reports of 5-fluorouracil induced serpentine supravenous hyperpigmentation. International Journal of Current Pharmaceutical & Clinical Research 2014;4(1):1-3.

Geddes ERC, Cohen PR. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy. South Med J. 2010; 103(3):231-5. doi:10.1097/SMJ.0b013e3181ce0f5e.

Payne BK. Weapon bias: Split-second decisions and unintended stereotyping. Curr Dir Psychol Sci.2006;15(6):287-91. doi.org/10.1111/j. 1467-8721.2006.00454.

Jamalpur I, Mogili HR, Koratala A. Serpentine supravenous hyperpigmentation. Clin Case Rep. 2017;5(9):1546-7. doi: 10.1002/ccr3.1102.

Aziz N, Faraz M, Sherwani MA, Fatma T, Prasad R.Illuminating the anticancerous efficacy of a new fungal chassis for silver nanoparticle synthesis. Front Chem.2019;7: article 65. doi.org/10.3389/fchem.2019.00065.

Akyurek FT, Sari N, Ugurluoglu C, Kurtipek GS.Serpentine supravenous hyperpigmentation related to carboplatin and vinorelbine chemotherapy: a case report.Dermatol Ther. 2019;32(4):e12981. doi: 10.1111/dth.12981.

Dodd M, Janson S, Facione N, Faucett J, Froelicher ES,Humphreys J, et al. Advancing the science of symptom management. J Adv Nurs. 2001;33(5):668-76. doi:10.1046/j.1365-2648.2001.01697.x.

Humphreys J, Janson S, Donesky DA, Dracup K, Lee KA,Puntillo K, et al. Theory of symptom management. In:Smith MJ & Liehr PR, editors. Middle range theory for nursing.3rded. New York: Springer;2014. p.141-84.

Bender MS, Janson SL, Linda SF, Lee KA. Theory of Symptom Management. In: Smith MJ & Liehr PR, editors.Middle range theory for nursing. 4th ed. New York:Springer ;2018. p.147-178.

Chen SC, Huang CY, Huang BS, Lin CY, Fan KH, Chang JT-C, et al. Factors associated with healthcare professional’s rating of disfigurement and self-perceived body image in female patients with head and neck cancer.Eur J Cancer Care (Engl). 2018;27(2):e12710. doi:10.1111/ecc.12710.

Cheewabantherng C, Roomruangwong C. Body image and its associated factors in patients with breast cancer with mastectomy at King Chulalongkorn Memorial Hospital.Chula Med J 2014 Sep - Oct; 58(5):563–76. (in Thai)

Phummarin N, Oranratanaphan S, Roomruangwong C.Body image and depression among gynecologic cancer patients at King Chulalongkorn Memorial Hospital. Chula Med Bull. 2019 Jan–Feb;1(1):79-92. (in Thai)

Yamane T, Statistics: an introductory analysis. 3rd ed.New York. Harper and Row Publications; 1973.

Aree-Ue S, Youngcharoen P. The 6 cognitive function test-Thai version: psychometric property testing.Ramathibodi Nursing Journal.2020;26(2),188-02.(in Thai)

Hopwood, P., Fletcher, I., Lee, A., & Al Ghazal, S.(2001). A body image scale for use with cancer patients.Eur J Cancer. 2001;37(2),189-97. doi:10.1016/s0959-8049(00)00353-1.

Cheewapoonpol B. Relationships between personal factors,fear of reactions of significant persons, coping strategies,social support, and body image of post mastectomy patients. Master’s thesis, Master of Nursing Science,Faculty of Nursing, Chulalongkorn University; 2004.(in Thai)

Rao R, Balachandran C. Serpentine supravenous pigmentation. A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil. Indian J Dermatol Venereol Leprol. 2010;76(6):714-5. doi: 10.4103/0378-6323.72459.

Hrushesky WJ. Letter: Serpentine supravenous fluorouracil hyperpigmentation. JAMA. 1976;236(2):138 doi:10.1001/jama.1976.03270020012002.

Somasekharan D, Narayanan B. Serpentine supravenous hyperpigmentation–a rare cutaneous manifestation in non-neoplastic conditions. J Skin Sex Transmitted Dis.2019;1: 97-100. doi:10.25259/JSSTD_28_2019.

Thaweethamcharoen T. Sunlight and skin care; 2017.[cited 2021 May 9]. Available from Faculty of Medicine Siriraj Hospital Web site: https://www.si.mahidol.ac.th/th/healthdetail.asp?aid=301

Khantichitr P, Kanogsunthornrat N, Sumdaengrit B.Pruritus, management strategies and outcomes as perceived by persons with cholangiocarcinoma. Journal of Nursing and Health Care. 2013;31(1):34-42. (in Thai)

Kim IR, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, etal. Perception, attitudes, preparedness and experience of chemotherapy-induced alopecia among breast cancer patients: a qualitative study. Asian Pac J Cancer Prev.2012;13(4):1383-8. doi: 10.7314/apjcp.2012.

4.1383.

Zamel ON, Inocian EP, Alshehry AS, Tumala RB,Patalagsa JG, Alsaleh KA. Quality of life among breast and colon cancer patients before and after first-cycle chemotherapy. Journal of holistic nursing. 2021;39(2):116–25. doi.org/10.1177/0898010 120958859.